Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Terlipressin for Injection

Approval Number

国药准字H20233814

Company海南皇隆制药股份有限公司

Registration Date

June 27, 2023

Drug Information

Generic Name

注射用特利加压素

Dosage Form

注射剂

Strength

1mg（相当于0.86mg特利加压素）

Drug Type

化学药品

Registration Date

June 27, 2023

Company Information

Applicant Company

Company Name海南皇隆制药股份有限公司

Company Address

海南省海口国家高新技术产业开发区药谷三横路8号

Manufacturing Company

Company Name海南皇隆制药股份有限公司

Company Address

海南省海口国家高新技术产业开发区药谷三横路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy